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Abstract
Plastic stent insertion is a treatment option for pan­
creatic duct stricture with chronic pancreatitis. However, 
recurrent stricture is a limitation after removing the 
plastic stent. Self­expandable metal stents have long 
diameters and patency. A metal stent has become an 
established management option for pancreatic duct 
stricture caused by malignancy but its use in benign 
stricture is still controversial. We introduce a young 
patient who had chronic pancreatitis and underwent 
several plastic stent insertions due to recurrent pan­
creatic duct stricture. His symptoms improved after 
using a fully covered self­expandable metal covered 
stent and there was no recurrence found at follow­up at 
the outpatient department.
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INTRODUCTION
The treatment of  chronic pancreatitis with pancreatic duct 
stricture is still challenging. Conventional plastic pancreatic 
duct (PD) stents are unsatisfactory because of  recurrent 
stricture and pain. Recently, self-expandable metal covered 
stents (SEMS) have been used to treat strictures of  the 
main pancreatic duct in chronic pancreatitis patients. 
How­ever, its long-term safety and efficacy are uncertain 
because of  epithelial hyperplasia and migration[1]. Some 
studies have demonstrated that a fully covered SEMS 
(FCSEMS) was effective in patients with symptomatic 
refractory PD stricture[2]. Here, we introduce a young 
patient with refractory PD stricture caused by chronic 
pancreatitis; the stricture and pain were effectively treated 
after placement of  FCSEMS. 
CASE REPORT
A 13 year old male visited Severance Hospital, Yonsei 
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University College of  Medicine with complaints of  re-
current abdominal pain. He was diagnosed with chronic 
pancreatitis at the age of  twelve. Magnetic resonance 
cholangiopancreatography (MRCP) showed chronic 
pancreatitis and a benign cystic lesion at the pancreatic 
groove, suggestive of  pseudocyst (2.7 cm) (Figure 1). For 
the treatment of  pancreatic pseudocyst, a cysto-duodenal 
stent (double pigtail, 4 cm) was inserted. One month later, 
computed tomography (CT) scan showed resolution of  
the cyst. At three months, the stent had disappeared on 
CT and no further treatment was provided as he had no 
symptoms. However, he returned with abdominal pain and 
vomiting six months after the first trial of  the stent. CT 
showed pancreatic duct dilatation with multiple persistent 
parenchymal or intraductal calcification, especially at the 
head of  pancreas head, and aggravation of  pseudocyst. 
A plastic PD stent (7 Fr, 5 cm) was inserted and then 
removed two months later. Another stent of  the same 
size was re-inserted as CT scan showed a remaining 
cyst. Four months later, pancreatogram showed diffuse 
dilatation of  the pancreatic duct and filling defects at the 
pancreatic head. A new PD stent with a larger diameter (10 
Fr, 5 cm) was inserted. He did not show any symptoms 
and was admitted to the hospital six months later during 
his winter break. The CT scan showed resolution of  the 
cyst. However, after removing the stent, pancreatogram 
showed an irregular stricture and proximal duct dilatation 
at the main pancreatic duct and pancreatic duct stones 
were found. Emergent mechanical lithotripsy was used 
for the treatment of  pancreatic stones and the stones 
were partially removed. He underwent extracorporeal 
shock wave lithotripsy (ESWL) in the urology department 
for two days and endoscopic retrograde cholangiopan-
creatography (ERCP) was done on the day after the last 
ESWL. The finding still show­ed PD stones w­ith reduced 
number and sizes. A plastic PD stent (10 Fr, 5 cm) was 
inserted for the treatment of  pancreatic duct stricture and 
stones. Four months after inserting the last plastic stent, 
ERCP show­ed no definite stricture at the pancreatic duct 
and the patient was followed up without additional stent 
insertion. Three months later, he again complained of  
abdominal pain. ERCP showed that the pancreatic duct 
was markedly dilated with a stenosis of  the head portion 
but without stones. To use a larger and more expandable 
device, a removable metal stent (Niti-S type biliary stent, 
covered, 10 mm, 5 cm, Taewoong, Seoul, Korea) was 
inserted into the pancreatic duct (Figure 2A). There 
were no procedure related complications. The patient re-
covered and was discharged after two days. The follow-
up ERCP was performed 1 mo after the stent placement 
and the stent was successfully removed with an elegator 
(Figure 2B). After removal of  the stent, the pancreatic 
duct stricture was much improved. Fifteen months after 
the stent removal, ERCP showed that the patency of  
the pancreatic duct was maintained (Figure 2C). The 
patient remains healthy without any signs or symptoms 
of  pancreatitis or need for any pancreatic enzyme supple-
ment or narcotics at 24 mo after stent removal.
DISCUSSION
About 50% of  patients with severe chronic pancreatitis 
undergoing endoscopic treatment require pancreatic stent 
placement in order to relieve obstruction of  the main 
pancreatic duct. Even though endoscopic placement of  
plastic stents has been widely used, it has several limi-
tations[3-5]. For example, since the plastic stents often 
become occluded with sludge, they usually need to be 
changed every 3 to 4 mo[6]. Thus, the number of  proce-
dures, hospitalization and costs may increase. As an 
alternative treatment for blockages of  plastic stent or 
refractory stricture after the plastic stent removal, the 
placement of  a metal stent has been considered. Metal 
stents have a longer patency than polyethylene stents and 
usually a single metal stent can palliate obstruction for 
good. The metal stent is effectively used in the treatment 
of  malignant pancreatic duct obstruction. In contrast, its 
use in patients with benign diseases has yet to be well-
established. There have been only a few studies regarding 
long-term complications, efficacy and outcomes with 
the use of  metal stent in benign disease[7]. In our study, 
the patient underwent removable metal stent insertion 
and remained not just free from pain but also had no 
recurrence of  pancreatitis for more than 2 years after the 
removal of  the metal stent. A follow-up pancreatogram 
also showed resolution of  dominant pancreatic ductal 
strictures. So far, results of  self-expandable uncovered 
metal stents had been disappointing with regard to poor 
drainage of  pancreatic juice and difficult removal due 
to tissue ingrowth[1,8]. Some studies even recommended 
that, considering complications such as increasing cancer 
risk or stent migration, SEMS should not be placed in 
patients with a benign gastrointestinal disorder, a long life 
expectancy and who are good candidates for surgery. To 
overcome these limitations, FCSEMS was developed. A 
FCSEMS with a larger diameter (up to 6 or 8 mm) may 
have an advantage in resolving or improving pancreatic 
ductal stricture compared with a single plastic stent[9]. In 
addition, the Niti-S type biliary stent (covered, Taewoong) 
used in this case has a double coated silver membrane 
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Figure 1  Initial magnetic resonance cholangiopancreatography showed 
chronic pancreatitis and pseudocyst.
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which prevents direct contact of  the metal with tissue, 
causes less tissue embedding and can be easily removed. 
Primary placement of  an FCSEMS may, therefore, be an 
attractive option for refractory benign pancreatic ductal 
strictures.
Recently, Park et al[9] showed that placement of  FC 
SEMS in patients with refractory benign pancreatic du-
ctal strictures for 2 mo might be feasible and relatively 
safe. Moon et al[10] reported that temporary 3 mo place-
ment of  modified FCSMS w­ith anti-migration features 
was effective in resolving pancreatic duct strictures in chr 
onic pancreatitis and reduced stent migration. Theo-
retically, they could provide better drainage and easy 
removability. However, in their reports, pancreatic sepsis 
or infection and cholestatic liver dysfunction were still 
common complications caused by metal stents. Even 
though FCSEMS seems to be promising, more tech 
 nological improvement is needed before applying FCS-
EMS in benign pancreatic diseases in order to be acce-
pted by more endoscopists. Also, further long-term fo 
llow-up studies are needed to determine the optimal 
duration and diameter of  FCSEMS for refractory benign 
pancreatic ductal strictures.
In this case study, a temporary 1 mo placement and 
removal of  a FCSEMS in the main pancreatic duct was 
deemed feasible and relatively safe. Moreover, the patient 
had no complications. We expect wider usage of  metal 
stents in benign pancreatic diseases after confirming its 
long-term efficacy and determining the optimal duration 
of  FCSEMS placement for refractory benign pancreatic 
ductal strictures through studies with a large number of  
patients.  
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Figure 2  Fully covered self-expandable metal stent. 
A: Niti-S type biliary covered stent was inserted; B: Metal 
stent was removed; C: Follow-up endoscopic retrograde 
cholangiopancreatography showed that the pancreatic duct 
was patent. 
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